MarketInOut Stock Screener Log In | Sign Up
 

BioNxt Solutions Inc

XETRA • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/19/2026 13:50
BioNxt Solutions Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeXETRA
Market Capitalization26.13 mln
Float123 mln
Earnings Date08/31/2025

Piotroski F-Score

2 / 9
Weak

Relative Strength

1 / 100
Severely lagging

Debt / Equity

-0.63
Negative equity

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Payout Ratio

0%
No payout

Business Description

BioNxt Solutions Inc. is a Canadian pharmaceutical company founded in 2017 and headquartered in Vancouver, focused on developing and selling advanced drug delivery products across Austria, Germany, and Switzerland. The company's pipeline targets a range of serious medical conditions, including multiple sclerosis, lupus, rheumatoid arthritis, and myasthenia gravis, alongside longevity and weight management treatments. BioNxt also develops diagnostic screening tools and works to refine how active pharmaceutical ingredients are delivered through the skin or as dissolvable oral films, with a particular interest in neurological applications.

Key Fundamentals

EPS-0.04
ROIC-202
ROA-867
EBITDA, mln-3.63
EV / EBITDA-11.04
EV / EBIT-11.02

Financial Strength

Piotroski F-Score 2 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.04% 1 / 100   
1 Month -21.67% 1 / 100   
2 Months -49.39% 0 / 100   
6 Months -47.85% 1 / 100   
1 Year -43.41% 3 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us